Abstract LB212: Efficacy and safety of JS015 (an anti-dickkopf-1 antibody) in combination with standard of care in patients with gastrointestinal cancers
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Tongji University, Shanghai East Hospital, Fujian Provincial Cancer Hospital, Hubei Cancer Hospital, Huazhong University of Science and Technology, Anhui Medical University, Second Affiliated Hospital of Anhui Medical University, First Hospital of China Medical University, Peking University, Peking University Cancer Hospital, Liaoning Cancer Hospital & Institute, Shandong Provincial Hospital, Shandong First Medical University, Jiangxi Provincial Cancer Hospital, Junshi Biosciences (China), China Pharmaceutical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409780818
